BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31473299)

  • 1. Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia".
    Maglie R; Grandi V; Antiga E
    J Am Acad Dermatol; 2020 Jan; 82(1):e15-e16. PubMed ID: 31473299
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia.
    Cohen PR
    J Am Acad Dermatol; 2020 Jan; 82(1):e13-e14. PubMed ID: 31473296
    [No Abstract]   [Full Text] [Related]  

  • 3. What's in a name? a new nomenclature has been proposed For eosinophilic dermatosis of hematologic malignancy (EDHM): hematologic-related malignancy-induced eosinophilic dermatosis (He Remained).
    Cohen PR
    Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?
    Qiao J; Sun CE; Zhu W; Zhu D; Fang H
    Int J Clin Exp Pathol; 2013; 6(8):1683-7. PubMed ID: 23923089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic dermatosis of hematologic malignancy.
    Farber MJ; La Forgia S; Sahu J; Lee JB
    J Cutan Pathol; 2012 Jul; 39(7):690-5. PubMed ID: 22612903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy.
    Maglie R; Ugolini F; De Logu F; Simi S; Senatore S; Montefusco F; Nassini R; Massi D; Antiga E
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e501-e503. PubMed ID: 33730368
    [No Abstract]   [Full Text] [Related]  

  • 7. Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature.
    Bari O; Cohen PR
    Dermatol Pract Concept; 2017 Jul; 7(3):6-15. PubMed ID: 29085714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic dermatosis of haematological malignancy.
    Jayasekera PS; Bakshi A; Al-Sharqi A
    Clin Exp Dermatol; 2016 Aug; 41(6):692-5. PubMed ID: 27378400
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed.
    Sibaud V; Brun A; Meyer N; Oberic L; Lamant L; Ysebaert L
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e213-e215. PubMed ID: 34657337
    [No Abstract]   [Full Text] [Related]  

  • 10. Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy.
    Meiss F; Technau-Hafsi K; Kern JS; May AM
    J Cutan Pathol; 2019 Mar; 46(3):175-181. PubMed ID: 30411384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic Dermatosis of Malignancy Involving the Eyelid.
    Ho TC; Compton L; Sheinbein D; Custer PL
    Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):e196-e198. PubMed ID: 34269770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic Dermatosis of Hematologic Malignancy.
    Lucas-Truyols S; Rodrigo-Nicolás B; Lloret-Ruiz C; Quecedo-Estébanez E
    Actas Dermosifiliogr; 2017; 108(6):e39-e44. PubMed ID: 28342533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.
    Jin A; Pousti BT; Savage KT; Mollanazar NK; Lee JB; Hsu S
    JAAD Case Rep; 2019 Sep; 5(9):815-817. PubMed ID: 31508473
    [No Abstract]   [Full Text] [Related]  

  • 14. Eosinophilic dermatosis of hematologic malignancy: Reality bites.
    Heymann WR
    J Am Acad Dermatol; 2019 Jul; 81(1):74-75. PubMed ID: 31059721
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center.
    Grandi V; Maglie R; Antiga E; Vannucchi M; Delfino C; Lastrucci I; Gunnella S; Ciolli S; Quintarelli L; Massi D; Caproni M; Pimpinelli N
    J Am Acad Dermatol; 2019 Jul; 81(1):246-249. PubMed ID: 30528498
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophilic dermatosis of hematologic malignancy.
    Martires K; Callahan S; Terushkin V; Brinster N; Leger M; Soter NA
    Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy.
    Lor M; Gates G; Yu Y
    Dermatol Ther; 2020 Nov; 33(6):e14206. PubMed ID: 32816408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic Eosinophilic Dermatosis in a Case of Chronic Lymphocytic Leukemia.
    Rajput CD; Nikam BP; Malani SS
    Indian Dermatol Online J; 2019; 10(1):61-63. PubMed ID: 30775302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term maintenance of eosinophilic dermatosis of hematologic malignancy with doxycycline.
    Mieczkowska K; Rzepecki AK; Jacob J; Amin B; Jacobson M; McLellan BN
    JAAD Case Rep; 2021 Oct; 16():110-112. PubMed ID: 34557577
    [No Abstract]   [Full Text] [Related]  

  • 20. Linear IgA dermatosis: association with malignancy.
    McEvoy MT; Connolly SM
    J Am Acad Dermatol; 1990 Jan; 22(1):59-63. PubMed ID: 2405029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.